Overexpression of basic fibroblast growth factoris a potential indicator of worse prognosis for patients with operable NSCLC and SCLC

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Basic fibroblast growth factor (bFGF) is known to stimulate angiogenesis, and overexpression is a potential indicator of worse prognosis for patients with operable non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

Study design

  • Meta-analysis of 22 studies (...